(Photo courtesy of Matthew D'Agostino/UMB)
Illumina’s first East Coast location is officially open in Baltimore.
On Tuesday, the San Diego-based genomics leader celebrated the grand opening of its new facility at the University of Maryland BioPark, the 14-acre research and technology park located to the west of downtown, and across Martin Luther King, Jr. Blvd. from the University of Maryland, Baltimore campus. The company announced its plans for the space over the summer.
Located in the BioPark building at 801 W. Baltimore St., the 13,000-square-foot Illumina Solutions Center will host trainings on the company’s technology. Illumina said it will host “hundreds” of customers and employees annually.
The office’s location across the street from the University of Maryland’s Institute of Genome Sciences was particularly attractive to the company, as the company was a collaborator with IGS and its director, Dr. Clare Fraser.
“We believe this location will facilitate collaborative engagement in research activities with our academic partner, University of Maryland, Baltimore,” said Mark Van Oene, Illumina senior VP and chief commercial officer, in a statement. “We are inspired by all the ways genomics can stimulate economic activity to maximize impact in the region and fuel research with the potential to improve health outcomes for patients.”
The opening adds a high profile to the BioPark, where more than 40 companies are currently operating. Looking ahead, BioPark real estate firm Wexford Science and Technologies is currently designing a new building along MLK Boulevard that will have more room for lab and office space over its 330,000 square feet.
This form of art blends science and technology to tell stories through biological products
Why Baltimore rose to the ‘top of the list’ when this biotech team needed a new HQ
KaloCyte moves to University of Maryland BioPark
How this lawyer is helping entrepreneurs bark up the right tree
UMB grants licensing option for anticancer drug that uses Anthrax
AgeneBio receives $3.4M for development of Alzheimer’s treatment
Frederick’s Veralox Therapeutics raises $5.4M seed round
Get to know SmartLogic’s culture of plants, podcasts and productive client relationships
Sign-up for daily news updates from Technical.ly Baltimore